Delivery of nitric oxide released from β-Gal-NONOate activation by β-galactosidase and its activity against Escherichia coli

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 6, 2006, Pages 1239-1241

  Chen, Chang ^a   Shi, Yan Qiu ^a   Song, Jing ^a   Qi, Qing Sheng ^a   Gu, Li ^a   Wang, Peng George ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

galactosyl pyrrolidinyl diazeniumdiolates ( Gal NONOate); Bactericidal activity; Nitric oxide; NO donor; Site specific delivery

Indexed keywords

BACTERICIDE; BETA GALACTOSIDASE; BETA GALACTOSYLPYRROLIDINYLDIAZENIUMDIOLATE DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE DONOR; PYRROLIDINYLDIAZENIUMDIOLATE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; NONHUMAN;

ANTI-BACTERIAL AGENTS; AZO COMPOUNDS; BETA-GALACTOSIDASE; COLONY COUNT, MICROBIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GALACTOSE; MICROBIAL VIABILITY; NITRIC OXIDE; NITRIC OXIDE DONORS;

EID: 33744931109     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1239     Document Type: Article

References (19)

1. Ignarro L. J., Angew. Chem. Int. Ed., 38, 1882-1892 (1999).
2. Furchgott R. F., Angew. Chem. Int. Ed., 38, 1870-1880 (1999).
3. Pfeiffer S., Mayer B., Hemmens B., Angew. Chem. Int. Ed., 38, 1714-1731 (1999).
4. Felman P. L., Griffith O. W., Stuehr D. J., Chem. Eng. News, 20, 26-38 (1993).
5. Bredt D. S., Snyder S. H., Annu. Rev. Biochem., 63, 175-195 (1994).
6. Liu J., Waalkes M. P., Toxicology, 208, 289-297 (2005).
7. Weller R., Clin. Sci. (London), 105, 533-535 (2003).
8. Serra P. A., Rocchitta G., Delogu M. R., Migheli R., Taras M. G., Mura M. P., Esposito G., Miele E., Desole M. S., Miele M., J. Neurochem., 86, 1403-1413 (2003).
9. Wang P. G., Xian M., Tang X. P., Wu X. J., Wen Z., Cai T. W., Janczuk A. J., Chem. Rev., 102, 1091-1134 (2002).
10. Wu X. J., Tang X. P., Xian M., Wang P. G., Tetrahedron Lett., 42, 3779-3782 (2001).
11. Sambrook J., Fritsch E. F., Maniatis T., "Molecular Cloning," A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989, pp. 808-809.
12. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R., Anal. Biochem., 126, 131-138 (1982).
13. Schmidt F., Ungureanu I., Duval R., Pompon A., Monneret C., Eur. J. Org. Chem., 2001, 2129-2134 (2001).
14. Desbene S., Van H. D., Michel S., Tillequin F., Koch M., Schmidt F., Florent J. C., Monneret C., Straub R., Czech J., Gerken M., Bosslet K., Anticancer Drug Des., 14, 93-106 (1999).
15. Radomski M. W., Moncada S., "Clinical Relevance of Nitric Oxide in the Cardiovascular System," ed. by Moncada S., Higgs E. A., Berrazueta E. R., Edicomplet, Madrid, Spain, 1991, pp. 45-56.
16. Battinelli E. M., Loscalzo J., "Nitric Oxide Cardiovascular System," ed. by Loscalzo J., Vita J. A., Humana Press Inc., Totowa, NJ, 2000, pp. 123-138.
17. Brennan P. A., Eur. J. Surg. Oncol., 26, 434-437 (2000).
18. Brunelli L., Crow J. P., Beckman J. S., Arch. Biochem. Biophys., 316, 327-334 (1995).
19. Saier M. H., Jr., Mol. Microbiol., 35, 699-710 (2000).